NIH-NINDS-22-002320-Notice of Intent

Submitted by patelsnv on Wed, 11/17/2021 - 14:30
Post Date/ Solicitation Issue Date
Closing Response Date
Proposed Award Date
Project Title
Genotyping reagents
Contracting Office
National Institute of Neurological Disorders and Stroke (NINDS)

Contact Points

Primary Contract Specialist

NAICS Code Number
Analytical Laboratory Instrument Manufacturing
Small Business Size Standard
1,000 employees
FPDS Classification Code
Estimated Period of Performance
Delivery of Goods
BLDG 35 RM 1A1000
Set-Aside Status
Not Set Aside
Competition Status
Brand Name Only
Vendor Name
Illlumina, Inc.
5200 Illumina Way
San Diego, CA 92122-4616
United States
Single-Sole Source Determination
Automated robotic Illumina genotyping systems require the use of proprietary reagents to ensure efficient operation and the desired outcomes of the operating systems. lllumina has been used successfully by our lab on multiple occasions for genotyping analysis. Illumina has performed in a high level of efficiency, delivered the reagents promptly and accurately. NDRU has purchased through competitive procedures a number of Illumina’s genotyping and sequencing systems which have proven platform for genetic analysis and functional genomics. Each of the Illumina systems requires the use of reagents and consumables to ensure efficient operation and the desired outcomes of the operating systems. Reagents are chemicals and enzymes used to perform an assay or research sequencing methodology. All reagents must be compatible with, and optimally perform in the Illumina manufactured systems. LNG uses standardized protocols with the Illumina equipment and there are additional protocols in process and at the development stage.
Background/Description of Requirement

Our Laboratory of Neurogenetics purchased Illumina brand equipment for whole exome sequencing and human genotyping back in 2007 and 2009 respectively. At the time, we paid   $458,560.00 in 2007, and $745,000.00 in 2009. Each year, we have been spending an estimated $90,000.00 on service contracts for our Illumina equipment. We have invested several millions of dollars in our sophisticated Illumina genotyping and sequencing equipment. The Illumina sequencing reagents have been specially designed and optimized to be run on our Illumina equipment, furthermore, these reagents are proprietary to Illumina and no other manufacturer provides these specific reagents and kits that are run along with our Illumina equipment

Interested parties may identify in writing their interest and capability in response to this requirement. Responses to this notice shall contain sufficient information to establish the interested parties’ bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM)

All responses must be received by closing date and must reference the announcement. Responses may be submitted electronically to the attention of the contract specialist. Fax responses will not be accepted.

All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency.